MAGE-3 and MAGE-4 genes as possible markers for early detection of metastases in hepatitis C virus Egyptian patients complicated by hepatocellular carcinoma

Medical Oncology

Volumn 29, Issue 2, 2012, Pages 994-999

  Hussein, Yousri M ^a   Ghareib, Amal F ^a   Mohamed, Randa H ^a   Radwan, Mohamed I ^a   Elsawy, Wael H ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Hepatocellular carcinoma; MAGE 3; MAGE 4

Indexed keywords

MELANOMA ANTIGEN 3; MELANOMA ANTIGEN 4; MESSENGER RNA; MAGEA3 PROTEIN, HUMAN; MAGEA4 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CHEMOEMBOLIZATION; CONTROLLED STUDY; DISTANT METASTASIS; FOLLOW UP; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOFREQUENCY ABLATION; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; EARLY DIAGNOSIS; EGYPT; FEMALE; GENETICS; HEPATITIS C VIRUS; LIVER; LIVER CIRRHOSIS; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COHORT STUDIES; EARLY DETECTION OF CANCER; EGYPT; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84866288255     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-9917-9     Document Type: Article

References (23)

1. Sakon M, Nagano H, Nakamori S, Dono K, Umeshita K, Murakami T, et al. Intrahepatic recurrences of hepatocellula carcinoma after hepatectomy: analysis based on tumor hemodynamics. Arch Surg. 2002;137:94-9.
2. Abrams P, Marsh JW. Current approach to hepatocellular carcinoma. Surg Clin North Am. 2010;90(4):803-16.
3. Mou DC, Cai SL, Peng JR, Wang Y, Chen HS, Pang XW, et al. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer. 2002;86:110-116.
4. Wong IH, Leung T, Ho S, Lau WY, Chan M, Johnson PJ. Semiquantitation of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. Br J Cancer. 1997;76(5):628-33.
5. Suzuki K, Tsujitani S, Konishi I, Yamaguchi Y, Hirooka Y, Kaibara N. Expression of MAGE genes and survival in patients with hepatocellular carcinoma. Int J Oncol. 1999;15:1227-32.
6. Baker PA, Salehi A. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res. 2002;67:705-12.
7. Nagao T, Higashitsuji H, Nonoguchi K, Sakurai T, Dawson S, Mayer RJ, et al. MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J Biol Chem. 2003;278 (12):10668-10674.
8. Kariyama K, Higashi T, Kobayashi Y, Nouso K, Nakatsukasa H, Yamano T, et al. Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma. Br J Cancer. 1999;81(6):1080-7.
9. Gunther FL, Hofbauer L, Schaefer C, Noppen C, Boni R, Kamarashev J, et al. MAGE-3 immunoreactivity in formalinfixed paraffin-embedded primary and metastatic melanoma. Am J Pathol. 1997;151:1549-53.
10. Chen CH, Huang GT, Lee HS, Yang PM, Yan MD, Chen DS, et al. High genes frequency in human of expression of MAGE hepatocellular carcinoma. Liver. 1999;19:110-4.
11. Tahara K, Mori M, Sadanaga N, Sakamoto Y, Kitano S, Makuuchi M. Expression of the MAGE gene family in human hepatocellular carcinoma. Cancer. 1999;85:1234-40.
12. Houghton RL, Dillon DC, Molesh DA, Zehentner BK, Xu J, Jiang J, et al. Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells. Mol Diagn. 2001;6(2):79-91.
13. Berois N, Varangot M, Aizen B, Estrugo R, Zarantonelli L, Fernández P, et al. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR. Eur J Cancer. 2000;36(6):717-723.
14. Jiang SY, Shyu RY, Huang MF, Tang HS, Young TH, Roffler SR, et al. Detection of alphafetoprotein expressing cells in the blood of patients with hepatoma and hepatitis. Br J Cancer. 1997;75:928-33.
15. Malek L, Jerome N, Herve Z, Abdelmajid S, Corinne V, Giovanna V, et al. Liver resection and needle liver biopsy cause hematogeneous dissemination of liver cells. Hepatology. 1999; 29:879-82.
16. Peck-Radosavljevic M, Pidlich J, Bergmann M, Ferenci P, Seelos C, Wichlas M, et al. Preoperative TNM-classification is a better prognostic indicator for recurrence of hepatocellular carcinoma after liver transplantation than albumin mRNA in peripheral blood. Liver Transplant Oncology Group. J Hepatol. 1998;28(3): 497-503.
17. Lemoine A, Le Bricon T, Salvucci M, Azoulay D, Pham P, Raccuia J, et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg. 1997;226(1):43-50.
18. Barbu V, Bonnand AM, Hillaire S, Coste T, Chazouilleres O, Gugenheim J, et al. Circulating albumin messenger RNA in hepatocellular carcinoma: results of a multicenter prospective study. Hepatology. 1997;26(5):1171-5.
19. Yuasa T, Okamoto K, Kawakami T, Mishina M, Ogawa O, Okada Y. Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue. J Urol. 2001;165:1790-4.
20. Zhang Y, Li Q, Liu N, Song T, Guo R, Meng L, et al. Multimarker detection of MAGE-1, MAGE-3 and AFP mRNAs by a real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma. Chin J Clin Oncol. 2008;5:93-8.
21. Tsuzuraharsa S, Sata M, Iwamoto O, Shichijo S, Kojiro M, Tanikawa K, et al. Detection of MAGE-4 protein in the sera of patients with hepatitis-c virus-associated hepatocellular carcinoma and liver cirrhosis. Jpn J Cancer Res. 1997;88:915-8.
22. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200-7.
23. Yanaga K. Current status of hepatic resection for hepatocellular carcinoma. J Gastroenterol. 2004;39:919-26.